Francisco Javier Melgosa Ramos , Carlos Abril Pérez , Santiago Guillén Climent , María Matellanes Palacios , Juncal Roca Ginés , Javier Sabater Abad , Eduardo Bernia Petit , Andrés Casanova Esquembre , Andrea Estébanez Corrales , Victor González Delgado
{"title":"upadacitinib治疗中重度特应性皮炎的中期有效性、安全性和潜在预测因素:一项多中心观察性回顾性研究","authors":"Francisco Javier Melgosa Ramos , Carlos Abril Pérez , Santiago Guillén Climent , María Matellanes Palacios , Juncal Roca Ginés , Javier Sabater Abad , Eduardo Bernia Petit , Andrés Casanova Esquembre , Andrea Estébanez Corrales , Victor González Delgado","doi":"10.1016/j.abd.2024.10.009","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 3","pages":"Pages 566-569"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective study\",\"authors\":\"Francisco Javier Melgosa Ramos , Carlos Abril Pérez , Santiago Guillén Climent , María Matellanes Palacios , Juncal Roca Ginés , Javier Sabater Abad , Eduardo Bernia Petit , Andrés Casanova Esquembre , Andrea Estébanez Corrales , Victor González Delgado\",\"doi\":\"10.1016/j.abd.2024.10.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7787,\"journal\":{\"name\":\"Anais brasileiros de dermatologia\",\"volume\":\"100 3\",\"pages\":\"Pages 566-569\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anais brasileiros de dermatologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0365059625000479\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anais brasileiros de dermatologia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0365059625000479","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective study
期刊介绍:
The journal is published bimonthly and is devoted to the dissemination of original, unpublished technical-scientific study, resulting from research or reviews of dermatological topics and related matters. Exchanges with other publications may be accepted.